Page 2 - Neuromuscular | UR Medicine
P. 2

Leading the World in Treatments





                                                 Patients around the world come to the University of Rochester
                                                 Medical Center for neuromuscular care. UR Medicine physicians
                                                 and scientists are making groundbreaking advances in the way we
                                                 understand neuromuscular diseases, and continue to lead worldwide
                                                 efforts to develop targeted therapies.

                                                 In 2001, the National Institutes of Health (NIH) named the

                                                 University of Rochester home to a first-of-its-kind registry of patients
                                                 who have been diagnosed with the two most common types of adult
                                                 muscular dystrophy. Led by Richard T. Moxley, III, M.D., registry
                                                 patients and researchers have been teaming up to make incredible
                                                 new discoveries. One of our studies indicates that a medication
                                                 commonly used to treat cardiac arrhythmias also relieves the
                                                 symptoms of myotonic dystrophy—an inherited disorder that is
        marked by progressive muscle weakness and stiffness—without side effects, leading to less pain and stiffness for
        many patients.


        Even more exciting, Charles A. Thornton, M.D., and his colleagues are moving steadily ahead on a therapy that
        has reversed the symptoms of myotonic dystrophy altogether in pre-clinical trials. The NIH awarded him a $4
        million grant to test his work with patients. This research could fundamentally alter the disease.

        The Saunders Research Building—a facility completely dedicated to clinical and translational research—is home
        to dedicated researchers and scientists working side-by-side to turn medical innovations into better treatments
        and cures more rapidly for patients.

        We are deeply grateful for donor support that has allowed our work to continue uninterrupted, and has resulted
        in great strides in our research. This generosity has enabled us to hire world class caregivers and investigators,

        and has ignited the possibility of new first-in-class treatments and therapies for complex neuromuscular diseases
        that affect millions of people. But we still have much work ahead of us. We won’t stop our quest to beat these
        terrible diseases.

        With your help, we can make even more progress in unlocking the mysteries of neuromuscular diseases. We
        invite you to join us as we blaze the path for a healthier future.

        Best Regards,







         Robert G. Holloway, M.D., M.P.H.
         Edward A. and Alma Vollertsen Rykenboer
         Chair in Neurophysiology
         Chair, Department of Neurology
         Professor of Neurology and Public Health Sciences




        On the cover: Charles A. Thornton, M.D., the Saunders Family Distinguished Professor in Neuromuscular Research and world-renowned
        neuromuscular clinician and researcher.
   1   2   3   4   5   6